← Evidence map

ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2022

A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales.

Rachid Rafia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35197225